Thrombo Genics Nv

15 email addresses found for thrombogenics.com
{first}-{last}@thrombogenics.com
15 email addresses
http://biospace.com/article/releases/new-thrombogenics-nv-ocriplasmin-clinical-and-health-economic-data-presented-at-b-asrs-b-2017-annual-scientific-meeting-in-boston- September 9, 2018
http://biospace.com/article/releases/novartis-ag-returns-global-eye-drug-rights-to-thrombogenics-nv- September 9, 2018
http://biospace.com/article/releases/thrombogenics-nv-presenting-thr-687-preclinical-data-at-b-european-association-for-vision-and-eye-research-b-ever-meeting- September 9, 2018
http://biospace.com/news/thrombogenics-nv-novartis-ag-win-eu-ok-for-jetrea/285164 September 9, 2018
http://ca.sys-con.com/node/2500248 April 4, 2015
http://catalystportal.co.uk/news/latest_news/bicycletherapeutics_announces_a_candidate_preclinical_milestone_in_it September 9, 2018
http://cnbc.com/2013/12/20/globe-newswire-thrombogenics-appoints-prof-dr-david-guyer-to-its-board-of-directors.html September 9, 2018
http://cnbc.com/2014/08/28/globe-newswire-thrombogenics-business-update-h1-2014.html September 9, 2018
http://cnbc.com/2014/10/14/globe-newswire-thrombogenics-commitment-to-the-us-retina-community-highlighted-at-american-association-of-ophthalmology-2014-meeting.html September 9, 2018
http://cnbc.com/2015/01/07/globe-newswire-thrombogenics-appoints-dominique-vanfleteren-as-new-chief-financial-officer.html September 9, 2018
http://cnbc.com/2015/09/10/globe-newswire-baron-philippe-vlerick-increases-shareholding-in-thrombogenics-nv-to-64.html September 9, 2018
http://docplayer.nl/2208064-thrombogenics-nv-business-update.html September 9, 2018
http://enternext.biz/category/trading-location/europe/brussels September 9, 2018
http://globenewswire.com/news-release/2014/06/24/646092/10086872/en/thrombogenics-provides-update-on-strategic-review-process.html September 9, 2018
http://inpublic.globenewswire.com/1977086.html August 8, 2018
http://medindia.net/health-press-release/thrombogenics-to-present-the-industry-pipeline-of-dme-treatments-at-upcoming-european-society-of-ophthalmology-congress-barcelona-spain-330232-1.htm September 9, 2018
http://prnewswire.com/news-releases/thrombogenics-confirms-jetrea-us-launch-date-of-monday-january-14th-2013-185627762.html September 9, 2018
http://prnewswire.com/news-releases/thrombogenics-enrolls-first-patients-in-phase-ii-clinical-study-evaluating-thr-317-anti-plgf-for-diabetic-macular-edema-dme-610197745.html August 8, 2018
http://prnewswire.com/news-releases/us-fda-approves-thrombogenics-jetrea-ocriplasmin-for-the-treatment-of-symptomatic-vitreomacular-adhesion-vma-174705351.html September 9, 2018
http://states1066.rssing.com/chan-13731545/all_p1240.html September 9, 2018
http://thestreet.com/story/11776730/3/jetrea-selected-for-single-technology-appraisal-sta-by-the-uks-national-institute-for-health-and-clinical-excellence-nice.html April 4, 2015
http://thestreet.com/story/11893576/5/thrombogenics-jetrea-the-first-and-only-medicine-for-treating-vitreomacular-traction-now-launched-in-the-uk.html May 5, 2015
http://thestreet.com/story/11911614/5/thrombogenics-jetrea-available-in-germany-public-and-private-market.html March 3, 2016
http://thestreet.com/story/11997501/4/germanys-iqwig-confirms-that-thrombogenics-jetrea-demonstrates-major-added-value-for-the-treatment-of-vitreomacular-traction-and-macular-hole.html May 5, 2015
http://thomsonreuters-yahoopartner.tumblr.com/page/114 August 8, 2018
http://thomsonreuters-yahoopartner.tumblr.com/page/31 September 9, 2018
http://thomsonreuters-yahoopartner.tumblr.com/page/85 May 5, 2018
http://thrombogenics.com/news-events/press-contact February 2, 2016
http://thrombogenics.com/nl/news-events/press-contact October 10, 2015
http://veterans342.rssing.com/chan-15021904/all_p361.html September 9, 2018
http://bio-medicine.org/biology-technology-1/microplasmin-meets-primary-endpoint-in-second-phase-iii-trial-in-vma--confirms-positive-findings-of-first-trial-17186-1 August 8, 2018
http://bio-medicine.org/medicine-technology-1/thrombogenics-begins-phase-iii-program-with-microplasmin-for-the-non-surgical-treatment-of-back-of-the-eye-disease-3676-1 August 8, 2017
http://bio-medicine.org/medicine-technology-1/thrombogenics-completes-patient-enrolment-for-phase-ii-trial-of-microplasmin-for-the-treatment-of-diabetic-macular-edema--28mivi-ii-dme-29-3968-1 August 8, 2018
http://bio-medicine.org/medicine-technology-1/thrombogenics-completes-patient-enrolment-in-us-phase-iii-trial-of-microplasmin-for-the-non-surgical-treatment-of-eye-disease-5051-1 August 8, 2017
http://bio-medicine.org/medicine-technology-1/thrombogenics-completes-patient-enrolment-of-second-phase-iii-trial-of-microplasmin-for-the-non-surgical-treatment-of-eye-disease-7032-1 August 8, 2017
http://biospace.com/news_print.aspx July 7, 2015
http://biospace.com/news/thrombogenics-ltd-and-bioinvent-complete/244042 February 2, 2015
http://digchip.com/companies_news/2009/2009_10_05_3.php December 12, 2017
http://drugs.com/clinical_trials/thrombogenics-announces-publication-positive-microplasmin-phase-ii-data-journal-retina-9825.html June 6, 2015
http://drugs.com/clinical_trials/thrombogenics-presents-positive-pooled-results-mivi-trust-phase-iii-program-confirming-microplasmin-10042.html April 4, 2015
http://medindia.net/health-press-release/thrombogenics-and-bioinvent-announce-the-start-of-new-study-of-novel-antibody-anti-cancer-agent-tb-403-anti-plgf--103114-1.htm July 7, 2018
http://medindia.net/health-press-release/thrombogenics-completes-patient-enrolment-of-second-phase-iii-trial-of-microplasmin-for-the-non-surgical-treatment-of-eye-disease--54791-1.htm July 7, 2018
http://mynewsdesk.com/se/pressreleases/positiva-resultat-fraan-fas-ii-studie-av-tb-402-publicerade-i-journal-of-thrombosis-and-haemostasis-578962 October 10, 2017
http://news.cision.com/se/bioinvent/r/positiva-resultat-fran-fas-ii-studie-av-tb-402-publicerade-i-journal-of-thrombosis-and-haemostasis,c546424 September 9, 2017
http://pr.gaeatimes.com/thrombogenics-and-bioinvent-complete-enrollment-of-phase-iib-trial-with-tb-402-ahead-of-schedule-54941 July 7, 2016
http://prnewswire.com/news-releases/microplasmin-meets-primary-endpoint-in-second-phase-iii-trial-in-vma-confirms-positive-findings-of-first-trial-101948448.html September 9, 2017
http://prnewswire.com/news-releases/thrombogenics-and-bioinvent-complete-enrollment-of-phase-iib-trial-with-tb-402-ahead-of-schedule-135717238.html May 5, 2015
http://au.sys-con.com/node/2464765 June 6, 2017
http://au.sys-con.com/node/2500250 August 8, 2015
http://bio-medicine.org/biology-technology-1/microplasmin-meets-primary-endpoint-in-second-phase-iii-trial-in-vma--confirms-positive-findings-of-first-trial-17186-1 August 8, 2018
http://bio-medicine.org/biology-technology-1/thrombogenics-announces-business-update-and-2008-full-year-results-10968-1 August 8, 2018
http://bio-medicine.org/biology-technology-1/thrombogenics-announces-results-from-a-phase-iia-trial-evaluating-microplasmin-for-the-treatment-of-diabetic-macular-edema--28mivi-ii-dme-29-14355-1 August 8, 2018
http://bio-medicine.org/medicine-technology-1/thrombogenics-begins-phase-iii-program-with-microplasmin-for-the-non-surgical-treatment-of-back-of-the-eye-disease-3676-1 August 8, 2018
http://bio-medicine.org/medicine-technology-1/thrombogenics-completes-patient-enrolment-for-phase-ii-trial-of-microplasmin-for-the-treatment-of-diabetic-macular-edema--28mivi-ii-dme-29-3968-1 August 8, 2018
http://biospace.com/article/releases/bioinvent-and-thrombogenics-ltd-to-receive-eur-10-million-milestone-as-partner-roche-begins-new-clinical-study-with-tb-403- September 9, 2018
http://biospace.com/news/fda-thrombogenics-nv-main-drug-cleared-for-u-s/276449 September 9, 2018
http://biospace.com/news/thrombogenics-ltd-and-bioinvent-complete/244042 September 9, 2018
http://biospace.com/news/thrombogenics-nv-novartis-ag-win-eu-ok-for-jetrea/285164 September 9, 2018
http://biospace.com/news/thrombogenics-nv-novartis-ag-win-eu-ok-for-jetrea/285164/source=topbreaking July 7, 2018
http://br.sys-con.com/node/2500250 August 8, 2015
http://businesswire.com/news/home/20130228006146/en/bioinvent-paper-cell-highlights-potential-role-tb-403 August 8, 2018
http://cnbc.com/2013/12/20/globe-newswire-thrombogenics-appoints-prof-dr-david-guyer-to-its-board-of-directors.html September 9, 2018
http://digchip.com/companies_news/2009/2009_10_05_3.php September 9, 2018
http://docplayer.nl/2208064-thrombogenics-nv-business-update.html September 9, 2018
http://medindia.net/health-press-release/thrombogenics-and-bioinvent-announce-the-start-of-new-study-of-novel-antibody-anti-cancer-agent-tb-403-anti-plgf--103114-1.htm October 10, 2018
http://medindia.net/health-press-release/thrombogenics-completes-patient-enrolment-of-second-phase-iii-trial-of-microplasmin-for-the-non-surgical-treatment-of-eye-disease--54791-1.htm October 10, 2018
http://medindia.net/health-press-release/thrombogenics-is-shortlisted-for-biotech-company-of-the-year-and-licensing-deal-of-the-year-at-scrip-awards-2009-44384-1.htm September 9, 2018
http://mynewsdesk.com/se/pressreleases/bioinvent-och-thrombogenics-initierar-naesta-dosnivaa-i-fas-ii-studien-med-tb-402-foer-foerebyggande-av-djup-ventrombos-dvt-306173 October 10, 2018
http://news.cision.com/se/bioinvent/r/bioinvent-och-thrombogenics-presenterar-positiva-resultat-fran-fas-ii-studie-av-tromboshammaren-tb-402-vid-internationell-kongress,c503110 March 3, 2018
http://pr.gaeatimes.com/thrombogenics-and-bioinvent-complete-enrollment-of-phase-iib-trial-with-tb-402-ahead-of-schedule-54941 January 1, 2018
http://prnewswire.com/news-releases/thrombogenics-and-bioinvent-complete-enrollment-of-phase-iib-trial-with-tb-402-ahead-of-schedule-135717238.html September 9, 2018
http://prnewswire.com/news-releases/thrombogenics-confirms-jetrea-us-launch-date-of-monday-january-14th-2013-185627762.html September 9, 2018
http://prnewswire.com/news-releases/thrombogenics-founder-prof-desire-collen-retiring-as-chairman-234815801.html September 9, 2018
http://prnewswire.com/news-releases/thrombogenics-receives-notice-from-fda-of-advisory-committee-meeting-for-ocriplasmin-157700645.html September 9, 2018
http://prnewswire.com/news-releases/us-fda-approves-thrombogenics-jetrea-ocriplasmin-for-the-treatment-of-symptomatic-vitreomacular-adhesion-vma-174705351.html September 9, 2018
http://prnewswire.co.uk/news-releases/thrombogenics-nv---business-update-177907291.html September 9, 2017
http://thestreet.com/story/11871593/1/thrombogenics-starts-trading-as-part-of-the-bel20-index-today.html May 5, 2017
http://au.sys-con.com/node/2464765 June 6, 2017
http://au.sys-con.com/node/2500248 June 6, 2017
http://au.sys-con.com/node/2500250 August 8, 2015
http://bio-medicine.org/biology-technology-1/thrombogenics-announces-business-update-and-2008-full-year-results-10968-1 March 3, 2016
http://bio-medicine.org/biology-technology-1/thrombogenics-nv-3a-business-update-12110-1 May 5, 2017
http://bio-medicine.org/biology-technology-1/thrombogenics-n-v--3a-business-update-8957-1 March 3, 2016
http://biospace.com/collaborative/news/thromb-x-nv-opens-new-u-s-headquarters/251902 May 5, 2017
http://biospace.com/news/fda-advisory-committee-recommends-thrombogenics-nv/268285 August 8, 2018
http://biospace.com/news/fda-thrombogenics-nv-main-drug-cleared-for-u-s/276449 September 9, 2018
http://biospace.com/news/thrombogenics-nv-novartis-ag-win-eu-ok-for-jetrea/285164 September 9, 2018
http://biospace.com/news/thrombogenics-nv-novartis-ag-win-eu-ok-for-jetrea/285164/source=topbreaking January 1, 2015
http://br.sys-con.com/node/2500248 July 7, 2018
http://br.sys-con.com/node/2500250 August 8, 2015
http://businesswire.com/news/home/20130228006146/en/bioinvent-paper-cell-highlights-potential-role-tb-403 March 3, 2016
http://ca.sys-con.com/node/2500248 June 6, 2018
http://cnbc.com/2013/12/20/globe-newswire-thrombogenics-appoints-prof-dr-david-guyer-to-its-board-of-directors.html September 9, 2018
http://drugs.com/nda/ocriplasmin_111227.html March 3, 2016
http://equities.com/companies/tbgnf September 9, 2018
http://in.sys-con.com/node/2464765 May 5, 2017
http://medindia.net/health-press-release/thrombogenics-is-shortlisted-for-biotech-company-of-the-year-and-licensing-deal-of-the-year-at-scrip-awards-2009-44384-1.htm September 9, 2018
http://oxurion.com/nl/content/thrombogenics-%e2%80%93-transparantieverklaring-0 September 9, 2018
http://prnewswire.com/news-releases/thrombogenics-and-bioinvent-to-regain-full-rights-to-tb-403-157132965.html May 5, 2015
http://prnewswire.com/news-releases/thrombogenics-confirms-jetrea-us-launch-date-of-monday-january-14th-2013-185627762.html September 9, 2018
http://prnewswire.com/news-releases/thrombogenics-founder-prof-desire-collen-retiring-as-chairman-234815801.html September 9, 2018
http://prnewswire.com/news-releases/thrombogenics-opens-new-us-headquarters-141445613.html March 3, 2016
http://prnewswire.com/news-releases/thrombogenics-receives-notice-from-fda-of-advisory-committee-meeting-for-ocriplasmin-157700645.html September 9, 2018
http://prnewswire.co.uk/news-releases/thrombogenics-nv---business-update-177907291.html January 1, 2018
http://tbgstaging.cxn.be/nl/content/thrombogenics-%e2%80%93-transparantieverklaring-0 September 9, 2018
http://thestreet.com/story/11530145/3/thrombogenics-nv--business-update.html March 3, 2016
http://uk.sys-con.com/node/2500248 March 3, 2016
Show more results
5 more results for thrombogenics.com. Sign up or log in to access the full and uncovered results.

Add the leading solution to find professional email addresses to your toolkit.

Hunter is already trusted by more than 1,000,000 professionals to build more connections and grow their business. Start today and get 100 free searches/month..

Google
IBM
Microsoft
Shopify
Adobe
Oracle

More information about thrombogenics.com

Language of the website: English